CompletedNot Applicable

Virtual Health Insurance Navigation Pilot Program for Colorectal Survivors

United States36 participantsStarted 2021-11-01

Plain-language summary

This trial aims to assess the feasibility and acceptability of colorectal survivors approached and engaged in HINT and aims to assess the preliminary efficacy of HINT to improve 1) health insurance literacy and 2) financial burden related to medical cost concerns colorectal survivors. The study investigators propose that, compared to the control arm (who will receive a health insurance information guide, but will not receive the navigation intervention), participants in the HINT intervention arm will have improved health insurance literacy and decreased financial distress related to medical costs.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who are18-65 years of age * patients who are 1) approximately 6 months to 5 years posttreatment for stages I-III colon or rectal cancer or 2) approximately more than 3 months post-diagnosis for stage IV colon or rectal cancer at the time of screening * patients who had a medical visit at MGH in the past two years * patients who have medical insurance * patients who speak English * patients who have access to an iPad, computer, smartphone or laptop with WIFI access Exclusion Criteria: * patients who are younger than 18 years of age or older than 65 years of age * patients who are unable to give consent due to psychiatric or cognitive impairment * patients who lack of access to a smartphone, computer, or tablet with internet access * patients who do not currently have health insurance

What they're measuring

Acceptability of the Health Insurance Navigation Program

Timeframe: 5 month follow-up

Change From Baseline Health Insurance Literacy to 5-month Follow-up

Timeframe: baseline and 5 month follow-up

Program Feasibility

Timeframe: 5-month follow-up

Trial details

NCT IDNCT05002608

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-30

Results submitted2025-02-24